Interocular symmetry of ganglion cell complex thickness in normal healthy subjects / 国际眼科杂志(Guoji Yanke Zazhi)

@#AIM: To investigate interocular differences in macular ganglion cell complex(mGCC)thickness in normal healthy subjects, and to determine cutoffs for interocular differences in mGCC thickness in normal healthy subjects.<p>METHODS: This was a cross-sectional study. mGCC thickness were measured in 236 healthy volunteers(472 eyes)using optical coherence tomography(OCT). The differences and the relationships of mGCC thickness between right and left eyes were analyzed. <p>RESULTS: For the right eyes, the mean average mGCC thickness was 91.99±6.61μm, and for the left, 91.75±9.93μm, with no significant difference. The mean mGCC thickness among superior and inferior in the right eye were 92.32±6.66μm and 91.27±8.87μm, respectively. The mean mGCC thickness among superior and inferior in the left eye were 92.05±6.55 and 91.51±6.76μm, respectively. It is comparable between the two eyes at different area. The P2.5 and P97.5 percentiles of interocular difference for mean average mGCC thickness were -4.82μm and 4.36μm, for superior mGCC thickness, -5.79μm and 6.42μm, and for inferior mGCC thickness, -7.21μm and 6.28μm. There was a strong correlation in the corresponding area between the right and left eyes for the mGCC thickness.<p>CONCLUSION: mGCC thickness shows significant interocular symmetry in normal subjects. Interocular difference exceeding the normal limits should be considered significantly asymmetrical, and may be indicative of glaucoma.

Effects of 1 g/L topical cyclosporine A in preventing pterygium recurrence after pterygium surgery / 国际眼科杂志(Guoji Yanke Zazhi)

AIM: To investigate the efficacy of 1g/L topical cyclosporine A ( tCsA ) in preventing the recurrence of pterygium after pterygium excision and conjunctival flap rotation technique. ●METHODS:Fifty-eight patients (58 eyes) with primary pterygium were included in this prospective study. All eyes were operated with pterygium excision and conjunctival flap rotation technique, and divided into treatment and control group according to whether be treated with 1g/L tCsA eye drops after operation. The operated patients were followed up for 1y to assess the recurrence of pterygium. ●RESULTS: After surgery, the difference between the tCsA treatment and control group were statistically significant in the Schirmer l test results (9. 93 ± 1. 59mm/5min vs 8. 47±1. 53mm/5min, P ●CONCLUSION:tCsA eye drops are safe and effective for medical treatment to reduce rates of recurrence after pterygium surgery.

Choroidal thickness and central serous chorioretinopathy：a case-control study and Meta-analysis / 国际眼科杂志(Guoji Yanke Zazhi)

AIM:To investigate the changes of subfoveal choroidal thickness ( SFCT ) in central serous chorioretinopathy ( CSCR) eyes and to compare them with normal control eyes. METHODS: This was a case-control study and a Meta-analysis. Forty - six CSCR patients diagnosed by the fundus pre - set lens, fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) were enrolled in this study. Sixty two age-, sex-, diopter- and axial length-matched 62 normal subjects ( 62 eyes ) were enrolled in this study as the control group. Using enhanced depth imaging optical coherence tomography ( EDI-OCT) , SFCT of CSCR eyes and normal control eyes were measured and compared. Univariate and multivariate linear regression analysis were performed to assess the association between SFCT and clinical factors. The Meta - analysis were conducted using the Stata software package to calculate the summary weighted mean differences ( WMDs) . RESULTS:The mean SFCT of the CSCR group and the normal control group was 397. 34±83. 91μm and 274. 48±62. 57μm, respectively. The CSCR eyes had a thicker choroid than the control eyes at the SFCT (P CONCLUSION:Along with the comprehensive Meta-analysis, SFCT in CSCR eyes was thicker than that of normal control eyes. Increased SFCT might be associated with CSCR.

Application of fresh amniotic membrane transplantation combined therapeutic soft corneal contact lens in pterygium / 国际眼科杂志(Guoji Yanke Zazhi)

To evaluate the clinical effect of therapeutic soft corneal contact lens in combination with fresh amniotic membrane transplantation in the treatment of pterygium and its clinical value. ●METHODS: This study was a retrospective analysis of 200 pterygium excision patients (200 cases, 220 eyes) in hospital from January 2010-June 2011. The patients were divided into two groups. Group 1 (100 cases, 110 eyes) were patients treated with fresh amniotic membrane transplantation and therapeutic soft corneal contact lens while group 2 ( control group, 100 cases, 110 eyes) did not use corneal contact lens. The clinical outcomes in these two groups were compared in a 6 - 18mo postoperative follow-up observation. ●RESULTS: ln control group using corneal contact lens the epithelium repair time ranged from 2 - 7d with an average time of 3. 8d; in group 1 the epithelial repair time ranged from 1 - 5d with an average time of 2. 5d. The patients were followed up for 6 - 18mo, 9 recurrent eyes were found in control group, the recurrence rate was 8. 2%; 5 recurrent eyes were found in experimental group the recurreat rate was 4. 5%. There were significant differences in the 2 groups comparing treatment outcomes (P ●CONCLUSlON:The therapeutic effect of fresh amniotic membrane transplantation after pterygium excision is enhanced by the therapeutic application of corneal contact lens. The epithelial repair time is shortened, the recurrence rate is reduced after pterygium excision and stimulative symptoms including photophobia, tearing, foreign body sensation and ophthalmodynia caused by corneal epithelial defect can be relieved.